Mark Schneider, Nestlé CEO (Ludovic Marin/Pool via AP Images)

Nestlé parts with peanut al­ler­gy treat­ment Pal­forzia

Peanut al­ler­gies proved a tough nut to crack for Nestlé, which an­nounced Mon­day it has di­vest­ed its treat­ment Pal­forzia to Swiss …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.